Super Session 2 - What’s hot in the eyes of international investors?
Wednesday, September 14, 2016
•
S3
•
11:15 AM
>
12:30 PM
•
Super Session 2 - What’s hot in the eyes of international investors?
•
Plenary Room A3
Hosted by Business Sweden
It is essential in the current changing climate for biotech and medtech companies to stay in tune with global trends and developments. This is your opportunity to meet investors actively investing in European life science companies and listen to what they are looking for. The presentation of several investors pitching in a row will be followed by a panel discussion. The moderator, Mike Ward from Scrip Intelligence, will no doubt ask some bold questions.
Moderator:
Mr. Mike Ward, Chief Content Officer, Datamonitor Healthcare & Scrip Intelligence, Informa
Introduction:
Ms. Ulrika Cederskog Sundling, Executive Vice President Invest & Government Assignments, Business Sweden
International Investors Pitches:
HealthCap - Sweden
Sunstone - Denmark
Aporia - USA
Novo Seeds - Denmark
Seventure Partners - France
Gilde Healthcare - Netherlands
Oberland Capital - Sweden
...
Panel Discussion Speakers:
Mr. Andreas Lindblom, Founder & CEO, Sciety
Dr. Nina Rawal, Head of Life Science, Industrifonden
Ms. Allison Hilton, Senior HealthCare Advisor, DNB
Ms. Meytal Waiss, Director of Business Development, FreeMind Group
|